Ica Group Wealth Management, LLC Astrazeneca PLC Transaction History

Ica Group Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $5,309 - $6,052	-87 Reduced 13.99%	535 $36,000
Q4 2023 Mar 07, 2024	BUY	$61.89 - $69.28 $38,495 - $43,092	622 New	622 $41,000
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $2,586 - $2,804	-37 Reduced 6.47%	535 $38,000
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $11,935 - $13,532	189 Added 49.35%	572 $39,000
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $20,762 - $26,978	383 New	383 $25,000

1,333

490M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $247B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Ica Group Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ica Group Wealth Management, LLC with notifications on news.